ArticleAnnals of biomedical engineering2026
Addition of PRG4 to Optimize the Anti-Adhesive Properties of Tissue Barrier Seprafilm
Article in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePostsurgical adhesion remains a significant clinical challenge. Seprafilm
methodsMacrophages (J774), human fibroblast-like synoviocytes (HFLS), and melanoma (A375) cells were cultured on tissue culture wells treated with rhPRG4 or bovine submaxillary mucin (BSM) to determine optimal seeding density. Seprafilm sheets were coated with rhPRG4 or BSM (0.78-200 µg/mL). Cell adhesion was quantified using CellTiter-Glo
resultsSeprafilm alone promoted HFLS and macrophage adhesion, whereas application of rhPRG4 significantly reduced adherence compared to both control and BSM coated surfaces. The combination of rhPRG4 with Seprafilm showed the greatest reduction in adhesion without compromising viability or re-adherence. Seprafilm alone increased macrophage migration and ROS production, while rhPRG4 coated surfaces alone or in combination with Seprafilm suppressed both.
conclusionCoating Seprafilm with rhPRG4 enhances its anti-adhesive properties by reducing adhesion, migration, and oxidative stress in vitro. These findings suggest rhPRG4 may improve the biological performance of adhesion barriers by suppressing early cellular infiltration and inflammatory activation. Anti-adhesive bioactive surface modifications may advance postsurgical adhesion prevention and wound healing.
Indexed as
Identifiers
42010021What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.